WRN and metabolic syndrome: It has been suggested that the inclusion of the WRN gene in genetic analyses for early-onset diabetes, lipodystrophy, or dyslipidemia may offer an opportunity to diagnose patients with Werner syndrome long before the presentation of the full spectrum of symptoms and complications, enabling earlier interventions, including malignant neoplasm screenings and prevention of diseases listed in the clinical criteria [58].